Cancer Drug Dosage Optimization Starts With US FDA Meetings Early In Development

 
• By Sue Sutter
Nuts and bolts
The FDA recognizes there is no one size fits all approach to cancer drug dosage optimization. • Source: Shutterstock

More from Clinical Trials

More from R&D